Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-09-11 08:23 am Sale | 13G | AXCELLA HEALTH INC AXLA | FMR LLC | 2,955,724 4.01% | -8,077,469 (-73.21%) | View |
| 2023-02-14 06:06 am Purchase | 13G | AXCELLA HEALTH INC AXLA | HarbourVest Partners L.P. | 6,207,929 8.4% | 1,829,268 (+41.78%) | View |
| 2023-02-09 08:23 am Purchase | 13G | AXCELLA HEALTH INC AXLA | FMR LLC | 11,033,193 14.999% | 5,195,708 (+89.01%) | View |
| 2023-02-02 5:16 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Societe des Produits Nestle S.A. | 11,105,438 15.09% | 6,799,897 (+157.93%) | View |
| 2022-10-17 4:32 pm Purchase | 13D | AXCELLA HEALTH INC AXLA | Flagship VentureLabs IV LLC | 29,251,545 39.8% | 10,383,760 (+55.03%) | View |
| 2022-09-23 4:31 pm Unchanged | 13D | AXCELLA HEALTH INC AXLA | Flagship VentureLabs IV LLC | 18,867,785 35.8% | 0 (Unchanged) | View |
| 2022-03-29 06:09 am Purchase | 13G | AXCELLA HEALTH INC AXLA | HarbourVest Partners L.P. | 4,378,661 8.46% | 1,570,680 (+55.94%) | View |
| 2022-03-18 08:30 am Purchase | 13D | AXCELLA HEALTH INC AXLA | Flagship VentureLabs IV LLC | 18,867,785 36.4% | 6,319,371 (+50.36%) | View |
| 2022-02-09 09:09 am Purchase | 13G | AXCELLA HEALTH INC AXLA | FMR LLC | 5,837,485 14.999% | 206,353 (+3.66%) | View |
| 2021-02-16 08:08 am Purchase | 13G | AXCELLA HEALTH INC AXLA | HarbourVest Partners L.P. | 2,807,981 7.5% | 1,578,947 (+128.47%) | View |
| 2021-02-12 1:52 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Societe des Produits Nestle S.A. | 4,305,541 11.47% | 4,305,541 (New Position) | View |
| 2021-02-08 10:17 am Purchase | 13G | AXCELLA HEALTH INC AXLA | FMR LLC | 5,631,132 14.999% | 2,419,210 (+75.32%) | View |
| 2020-09-09 8:00 pm Unchanged | 13G | AXCELLA HEALTH INC AXLA | Nestle Health Science US Holdings Inc. | 4,305,541 11.81% | 0 (Unchanged) | View |
| 2020-05-21 5:01 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Nestle Health Science US Holdings Inc. | 4,305,541 12% | 1,936,842 (+81.77%) | View |
| 2020-05-20 5:00 pm Purchase | 13D | AXCELLA HEALTH INC AXLA | Flagship VentureLabs IV LLC | 12,548,414 35% | 3,800,000 (+43.44%) | View |
| 2020-02-13 2:14 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Nestle Health Science US Holdings Inc. | 2,368,699 10.2% | 2,368,699 (New Position) | View |
| 2020-02-07 4:10 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Gurnet Point L.P. | 1,293,891 5.6% | 1,293,891 (New Position) | View |
| 2020-02-07 11:12 am Purchase | 13G | AXCELLA HEALTH INC AXLA | FMR LLC | 3,211,922 13.896% | 53,344 (+1.69%) | View |
| 2020-02-05 4:30 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | HarbourVest Partners L.P. | 1,229,034 5.3% | 1,229,034 (New Position) | View |
| 2019-06-10 11:51 am Purchase | 13G | AXCELLA HEALTH INC AXLA | FMR LLC | 3,158,578 13.739% | 3,158,578 (New Position) | View |